Advertisement |
BIO-TECHNE CORP (TECH:NASDAQ)
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023 and has approximately 3,200 employees worldwide.
Yearly Figures
(in thousands, except per share amounts) | ||||
FYE: 6/30 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Net Revenues | $1,136,702 | $1,105,599 | $931,032 | $738,691 |
Net Income | $285,263 | $272,051 | $140,410 | $229,296 |
Earnings Per Share | 1.76 | 1.66 | 0.87 | 1.13 |
Quarterly Figures
(in thousands, except per share amounts) | ||||
Second Quarter | ||||
FYE: 6/30 | 12/31/23 | 12/31/22 | ||
Net Revenues | $272,598 | $271,581 | ||
Net Income | $27,465 | $50,005 | ||
Earnings Per Share | 0.17 | 0.31 |
Contact Information
Contact Name: | Kathy Backes |
Contact Title: | Controller |
Phone: | (800) 328-2400 |